IDYA ▲ +0.4% - IDEAYA Biosciences, Inc.
$IDYA IDYA - IDEAYA Biosciences and Servier Announce Data From Three Clinical Trials at ESMO 2026 Supporting the Potential of Darovasertib to Become a Foundational New Therapy for Patients Across the Treatment Journey of Uveal Melanoma
19-OCT-2026 06:00 AM ET
Share this post
More filings for $IDYA
IDYA ▼ -0.1% - IDEAYA Biosciences, Inc.Sep 28, 2026IDYA ▲ +1.1% - IDEAYA Biosciences, Inc.Sep 9, 2026IDYA ▲ +2.2% - IDEAYA Biosciences, Inc.Aug 31, 2026IDYA ▲ +0.2% - IDEAYA Biosciences, Inc.Aug 28, 2026$IDYA SEC Filing Update (31-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 31, 2026
View full $IDYA filing history →💬 Comments
Loading comments…
Leave a comment